Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Liabilities and Shareholders Equity (2023 - 2025)

SeaStar Medical Holding's Liabilities and Shareholders Equity history spans 3 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 202.13% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $45.7 million, up 123.05%, while the annual FY2025 figure was $14.2 million, 202.13% up from the prior year.
  • Liabilities and Shareholders Equity reached $14.2 million in Q4 2025 per ICUCW's latest filing, down from $15.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $15.5 million in Q3 2025 to a low of $2.5 million in Q3 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $6.5 million, with a median of $4.6 million recorded in 2024.
  • The largest YoY upside for Liabilities and Shareholders Equity was 238.64% in 2025 against a maximum downside of 1.85% in 2025.
  • A 3-year view of Liabilities and Shareholders Equity shows it stood at $3.5 million in 2023, then soared by 33.79% to $4.7 million in 2024, then soared by 202.13% to $14.2 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Liabilities and Shareholders Equity are $14.2 million (Q4 2025), $15.5 million (Q3 2025), and $8.4 million (Q2 2025).